Retrieved 17 of January 14, 2015 V&A/authorization determines variation: B.I. to z) for the medicine: NEBIVOLOL ACTAVIS European procedure: DE/H/0979/001/II/013 Mah: Actavis Group PTC EHF is hereby amended as follows: update of the DMF of active ingredient Nebivolol hydrochloride: Hetero by 2012 to 2013 September version July version (AP-00 and RP-00) with regard to marketing authorisations authorised pack sizes in Italy following the mutual recognition procedure.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1, paragraph 5, of the causes of the April 14, 2014 # 371 AIFA published in Official Gazette No 101 of May 3, 2014.
Date of determination: from the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica Italiana.